Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicles on the scalp interact with and respond to the nervous system, influencing their own behavior and growth.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Animal models, especially mice, are essential for advancing hair loss research and treatment.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

A girl with hereditary chorea, likely Huntington's disease, had her condition worsened by lupus.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Melanocytes are diverse cells important for pigmentation and skin health, influenced by genetics and environment.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Researchers created a model to understand heart aging, highlighting the role of microRNAs and identifying key genes and pathways involved.

The document says that hookworms are treated with mebendazole and stress-related hair loss usually gets better in 6 months, while other hair loss types have specific treatments.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Some alternative treatments for hair loss might work, but more research is needed.

Hair loss improved with treatment and successful transplant.

Using neurohormones to control keratin can lead to new skin disease treatments.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

People with alopecia areata have higher insulin resistance.

Some vaccines, like the hepatitis B vaccine, might be linked to the hair loss condition Alopecia Areata, but more research is needed.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Minoxidil in breast milk may harm nursing infants.